메뉴 건너뛰기




Volumn 102, Issue 6, 2009, Pages 1176-1182

Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease: Beneficial effects of simvastatin treatment

Author keywords

Coagulation; Fibrin; Fibrinolysis; Inflammation; Statins

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRIN; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

EID: 72949119341     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-02-0118     Document Type: Article
Times cited : (85)

References (33)
  • 1
    • 33845361633 scopus 로고    scopus 로고
    • Mortality in COPD: Role of comorbidities
    • Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245-1257.
    • (2006) Eur Respir J , vol.28 , pp. 1245-1257
    • Sin, D.D.1    Anthonisen, N.R.2    Soriano, J.B.3
  • 2
    • 0036683267 scopus 로고    scopus 로고
    • Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study
    • Anthonisen NR, Connett JE, Enright PL, et al. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-339.
    • (2002) Am J Respir Crit Care Med , vol.166 , pp. 333-339
    • Anthonisen, N.R.1    Connett, J.E.2    Enright, P.L.3
  • 3
    • 27144484127 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in COPD
    • Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646.
    • (2005) Chest , vol.128 , pp. 2640-2646
    • Huiart, L.1    Ernst, P.2    Suissa, S.3
  • 4
    • 0037465734 scopus 로고    scopus 로고
    • Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
    • Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519.
    • (2003) Circulation , vol.107 , pp. 1514-1519
    • Sin, D.D.1    Man, S.F.2
  • 5
    • 84878089110 scopus 로고    scopus 로고
    • Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease
    • Undas A, Celinska-Lowenhoff M, Lowenhoff T, et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 2006; 4: 1029-1036.
    • (2006) J Thromb Haemost , vol.4 , pp. 1029-1036
    • Undas, A.1    Celinska-Lowenhoff, M.2    Lowenhoff, T.3
  • 6
    • 34548096913 scopus 로고    scopus 로고
    • Altered fibrin clot structure in patients with advanced coronary artery disease: A role of C-reactive protein, lipoprotein(a), and homocysteine
    • Undas A, Plicner D, Stepien E, et al. Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a), and homocysteine. J Thromb Haemost 2007; 5: 1988-1990.
    • (2007) J Thromb Haemost , vol.5 , pp. 1988-1990
    • Undas, A.1    Plicner, D.2    Stepien, E.3
  • 7
    • 38349167097 scopus 로고
    • Identification and distribution of fibrinogen, fibrin, and fibrin( ogen) degradation products in atherosclerosis
    • Bini A, Fenoglio J, Mesa-Tejada E, et al. Identification and distribution of fibrinogen, fibrin, and fibrin( ogen) degradation products in atherosclerosis. Atherosclerosis 1989; 69: 1038-1045.
    • (1989) Atherosclerosis , vol.69 , pp. 1038-1045
    • Bini, A.1    Fenoglio, J.2    Mesa-Tejada, E.3
  • 8
    • 0024457394 scopus 로고
    • Atherosclerosis and the coagulation system
    • Thompson W, Smith E. Atherosclerosis and the coagulation system. J Pathol 1989; 159: 97-106.
    • (1989) J Pathol , vol.159 , pp. 97-106
    • Thompson, W.1    Smith, E.2
  • 9
    • 0034964447 scopus 로고    scopus 로고
    • The structure and biological features of fibrinogen and fibrin
    • Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci 2001; 936: 11-30.
    • (2001) Ann NY Acad Sci , vol.936 , pp. 11-30
    • Mosesson, M.W.1    Siebenlist, K.R.2    Meh, D.A.3
  • 10
    • 0028050537 scopus 로고
    • Fibrin in human plasma: Gel architecture governed by rate and nature of fibrinogen activation
    • Blombäck B, Carlsson K, Fatah K, et al. Fibrin in human plasma: gel architecture governed by rate and nature of fibrinogen activation. Thromb Res 1994; 5: 521-538.
    • (1994) Thromb Res , vol.5 , pp. 521-538
    • Blombäck, B.1    Carlsson, K.2    Fatah, K.3
  • 11
    • 0038353228 scopus 로고    scopus 로고
    • Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots
    • Collet JP, Lesty C, Montalescot G,. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J Biol Chem 2003; 278: 21331-21335.
    • (2003) J Biol Chem , vol.278 , pp. 21331-21335
    • Collet, J.P.1    Lesty, C.2    Montalescot, G.3
  • 12
    • 4444376338 scopus 로고    scopus 로고
    • Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease
    • Scott EM, Ariëns RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.
    • (2004) Arterioscler Thromb Vasc Biol , vol.24 , pp. 1558-1566
    • Scott, E.M.1    Ariëns, R.A.S.2    Grant, P.J.3
  • 13
    • 33646583539 scopus 로고    scopus 로고
    • Fibrin clot structure and cardiovascular disease
    • Undas A, Zeglin M. Fibrin clot structure and cardiovascular disease. Vasc Dis Prevention 2006; 3: 99-106.
    • (2006) Vasc Dis Prevention , vol.3 , pp. 99-106
    • Undas, A.1    Zeglin, M.2
  • 14
    • 33745034815 scopus 로고    scopus 로고
    • Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects
    • Undas A, Brozek J, Jankowski M, et al. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol 2006; 26: 1397-1404.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 1397-1404
    • Undas, A.1    Brozek, J.2    Jankowski, M.3
  • 15
    • 33645647601 scopus 로고    scopus 로고
    • Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis
    • Undas A, Stepien E, Tracz W, et al. Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost 2006; 4: 973-975.
    • (2006) J Thromb Haemost , vol.4 , pp. 973-975
    • Undas, A.1    Stepien, E.2    Tracz, W.3
  • 16
    • 0021266859 scopus 로고
    • Binding of fibronectin by the acute phase C-reactive protein
    • Salonen EM, Vartio T, Hedman K. Binding of fibronectin by the acute phase C-reactive protein. J Biol Chem 1984; 259: 1496-1501.
    • (1984) J Biol Chem , vol.259 , pp. 1496-1501
    • Salonen, E.M.1    Vartio, T.2    Hedman, K.3
  • 17
    • 0028143826 scopus 로고
    • Differential susceptibility of plasma proteins to oxidative modification: Examination by western blot immunoassay
    • Shacter E, Williams JA, Lim M, et al. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med 1994; 17: 429-437.
    • (1994) Free Radic Biol Med , vol.17 , pp. 429-437
    • Shacter, E.1    Williams, J.A.2    Lim, M.3
  • 18
    • 21344453992 scopus 로고    scopus 로고
    • The influence of type 2 diabetes on fibrin structure and function
    • Dunn EJ, Ariëns RA, Grant PJ. The influence of type 2 diabetes on fibrin structure and function. Diabetologica 2005; 48: 1198-1206.
    • (2005) Diabetologica , vol.48 , pp. 1198-1206
    • Dunn, E.J.1    Ariëns, R.A.2    Grant, P.J.3
  • 19
    • 0029562794 scopus 로고
    • The effect of acetyl salicylic acid on fibrin gel lysis by tissue plasminogen activator
    • Williams S, Fatah K, Ivert T, et al. The effect of acetyl salicylic acid on fibrin gel lysis by tissue plasminogen activator. Blood Coagul Fibrinolysis 1995; 6: 718-725.
    • (1995) Blood Coagul Fibrinolysis , vol.6 , pp. 718-725
    • Williams, S.1    Fatah, K.2    Ivert, T.3
  • 20
    • 33744994082 scopus 로고    scopus 로고
    • Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
    • Mancini GB, Etminan M, Zhang B, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol. 2006; 47: 2554-2560.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2554-2560
    • Mancini, G.B.1    Etminan, M.2    Zhang, B.3
  • 21
    • 0037044451 scopus 로고    scopus 로고
    • Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease
    • Mills JD, Ariens RA, Mansfield MW, et al. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation. 2002; 106: 1938-1942.
    • (2002) Circulation , vol.106 , pp. 1938-1942
    • Mills, J.D.1    Ariens, R.A.2    Mansfield, M.W.3
  • 22
    • 0032728127 scopus 로고    scopus 로고
    • Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: Influence of plasma biochemical modifications
    • Collet J-P, Mishal Z, Lesty C, et al. Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: influence of plasma biochemical modifications. Thromb Haemost 1999; 82: 1482-1489.
    • (1999) Thromb Haemost , vol.82 , pp. 1482-1489
    • Collet, J.-P.1    Mishal, Z.2    Lesty, C.3
  • 23
    • 33750209018 scopus 로고    scopus 로고
    • Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis
    • Collet J-P, Allali Y, Lesty C, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006; 26: 2567-2573.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 2567-2573
    • Collet, J.-P.1    Allali, Y.2    Lesty, C.3
  • 24
    • 67650463092 scopus 로고    scopus 로고
    • Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l
    • Undas A, Topor-Madry R, Tracz W. Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l. Pol Arch Med Wewn. 2009; 119: 354-359.
    • (2009) Pol Arch Med Wewn , vol.119 , pp. 354-359
    • Undas, A.1    Topor-Madry, R.2    Tracz, W.3
  • 25
    • 0036802128 scopus 로고    scopus 로고
    • Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk
    • Gonbert S, Malinsky S, Sposito AC, et al. Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk. Atherosclerosis 2002; 164: 305-311.
    • (2002) Atherosclerosis , vol.164 , pp. 305-311
    • Gonbert, S.1    Malinsky, S.2    Sposito, A.C.3
  • 26
    • 65549089130 scopus 로고    scopus 로고
    • Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension
    • Lee TM, Chen CC, Shan HN, et al. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Clin Sci (Lond) 2009; 116: 497-505.
    • (2009) Clin Sci (Lond) , vol.116 , pp. 497-505
    • Lee, T.M.1    Chen, C.C.2    Shan, H.N.3
  • 27
    • 34548669619 scopus 로고    scopus 로고
    • Cardiovascular risk in chronic obstructive pulmonary disease
    • Maclay JD, McAlister DA, MacNee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007; 12: 634-641.
    • (2007) Respirology , vol.12 , pp. 634-641
    • Maclay, J.D.1    McAlister, D.A.2    MacNee, W.3
  • 28
    • 33846008765 scopus 로고    scopus 로고
    • Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: Beneficial effects of statins
    • Lahera V, Goicoechea M, de Vinuesa SG, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem 2007; 14: 243-248.
    • (2007) Curr Med Chem , vol.14 , pp. 243-248
    • Lahera, V.1    Goicoechea, M.2    de Vinuesa, S.G.3
  • 29
    • 38349133637 scopus 로고    scopus 로고
    • Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress
    • Undas A, Szuldrzynski K, Stepien E, et al. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis 2007; 196:551-558.
    • (2007) Atherosclerosis , vol.196 , pp. 551-558
    • Undas, A.1    Szuldrzynski, K.2    Stepien, E.3
  • 30
    • 0036209320 scopus 로고    scopus 로고
    • Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease
    • Ashitani J, Mukae H, Arimura Y, et al. Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease. Int Medicine 2002; 41: 181-185.
    • (2002) Int Medicine , vol.41 , pp. 181-185
    • Ashitani, J.1    Mukae, H.2    Arimura, Y.3
  • 31
    • 33747600439 scopus 로고    scopus 로고
    • Systemic inflammation in patients with COPD and pulmonary hypertension
    • Joppa P, Petrasova D, Stancak B, et al. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006; 130: 326-333.
    • (2006) Chest , vol.130 , pp. 326-333
    • Joppa, P.1    Petrasova, D.2    Stancak, B.3
  • 32
    • 0008706178 scopus 로고
    • Sclerosis of pulmonary artery with thrombosis
    • Brenner O, Birm MD, Long M. Sclerosis of pulmonary artery with thrombosis. Lancet 1931; 1: 911-914.
    • (1931) Lancet , vol.1 , pp. 911-914
    • Brenner, O.1    Birm, M.D.2    Long, M.3
  • 33
    • 26244467021 scopus 로고    scopus 로고
    • C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: Evidence that CRP is prothrombotic
    • Singh U, Deveraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that CRP is prothrombotic. Arterioscler Thromb Vasc Biol 2005; 25: 2216-2221.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 2216-2221
    • Singh, U.1    Deveraj, S.2    Jialal, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.